One-year safety and efficacy of ustekinumab and results of dose adjustment after switching from inadequate methotrexate treatment: the TRANSIT randomized trial in moderate-to-severe plaque psoriasisREICH, K; PUIG, L; BRUNORI, M et al.British journal of dermatology (1951). 2014, Vol 170, Num 2, pp 435-444, issn 0007-0963, 10 p.Article

Transition to ustekinumab in patients with moderate-to-severe psoriasis and inadequate response to methotrexate: a randomized clinical trial (TRANSIT)PAUL, C; PUIG, L; MISTRY, S et al.British journal of dermatology (1951). 2014, Vol 170, Num 2, pp 425-434, issn 0007-0963, 10 p.Article